{"altmetric_id": 82124185, "counts": {"readers": {"citeulike": "0", "mendeley": "54", "connotea": "0"}, "total": {"posts_count": 32}, "twitter": {"unique_users_count": 26, "posts_count": 29}, "patent": {"unique_users_count": 3, "unique_users": ["patent:US-10787501-B1", "patent:US-10954289-B1", "patent:US-10975139-B1"], "posts_count": 3}}, "citation": {"altmetric_jid": "532721422a83ee84788b4567", "authors": ["Ejemel, Monir", "Li, Qi", "Hou, Shurong", "Schiller, Zachary A.", "Wallace, Aaron L.", "Amcheslavsky, Alla", "Yilmaz, Nese Kurt", "Toomey, Jacqueline R.", "Schneider, Ryan", "Close, Brianna J.", "Chen, Da-Yuan", "Conway, Hasahn L.", "Mohsan, Saeed", "Cavacini, Lisa A.", "Klempner, Mark S.", "Schiffer, Celia A.", "Wang, Yang"], "doi": "10.1101/2020.05.15.096719", "first_seen_on": "2020-05-15T22:09:42+00:00", "issns": [], "journal": "bioRxiv", "last_mentioned_on": 1618272000, "links": ["https://www.biorxiv.org/content/10.1101/2020.05.15.096719v1", "https://www.biorxiv.org/content/10.1101/2020.05.15.096719v1?utm_source=Twitter-CovidNewsBot", "https://www.ncbi.nlm.nih.gov/pubmed/32511396", "https://doi.org/10.1101/2020.05.15.096719"], "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/05/15/2020.05.15.096719.full.pdf", "pmid": "32511396", "publisher": "Cold Spring Harbor Laboratory", "title": "IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/c48c95d5-1dc0-3a8d-be83-95114831dfc5/"}, "altmetric_score": {"score": 15.35, "score_history": {"1y": 15.35, "6m": 3, "3m": 3, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 15.35}, "context_for_score": {"all": {"total_number_of_other_articles": 17674883, "mean": 9.4355274911831, "rank": 1473762, "this_scored_higher_than_pct": 91, "this_scored_higher_than": 16200906, "rank_type": "exact", "sample_size": 17674883, "percentile": 91}, "similar_age_3m": {"total_number_of_other_articles": 286386, "mean": 20.169666366372, "rank": 40717, "this_scored_higher_than_pct": 85, "this_scored_higher_than": 245595, "rank_type": "exact", "sample_size": 286386, "percentile": 85}, "this_journal": {"total_number_of_other_articles": 120556, "mean": 13.883411128439, "rank": 24030, "this_scored_higher_than_pct": 80, "this_scored_higher_than": 96473, "rank_type": "exact", "sample_size": 120556, "percentile": 80}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 8464, "mean": 19.636668241966, "rank": 1738, "this_scored_higher_than_pct": 79, "this_scored_higher_than": 6721, "rank_type": "exact", "sample_size": 8464, "percentile": 79}}}, "demographics": {"poster_types": {"member_of_the_public": 18, "researcher": 7, "science_communicator": 1}, "users": {"twitter": {"cohorts": {"Members of the public": 18, "Scientists": 7, "Science communicators (journalists, bloggers, editors)": 1}}, "mendeley": {"by_status": {"Student  > Postgraduate": 1, "Professor > Associate Professor": 1, "Researcher": 13, "Student  > Master": 5, "Student  > Ph. D. Student": 6, "Professor": 1, "Student  > Bachelor": 9, "Student  > Doctoral Student": 1, "Other": 6, "Unspecified": 2}, "by_discipline": {"Engineering": 2, "Chemistry": 2, "Neuroscience": 3, "Medicine and Dentistry": 20, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 3, "Agricultural and Biological Sciences": 2, "Nursing and Health Professions": 1, "Biochemistry, Genetics and Molecular Biology": 8, "Environmental Science": 1, "Unspecified": 2}}}, "geo": {"twitter": {"US": 6, "FR": 1, "BR": 1, "GB": 1, "CA": 1, "CH": 1, "IT": 2}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1949132852"}, "tweet_id": "1261418414658260993"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "748908558066982916"}, "tweet_id": "1261418415652319238"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1259054648"}, "tweet_id": "1261419632822349825"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "2414645220"}, "tweet_id": "1261420256528150530"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "2414645220"}, "tweet_id": "1261420506156273665"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "48349524"}, "tweet_id": "1261420768749068297"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1225775809446785024"}, "tweet_id": "1261421032579055616"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1225775809446785024"}, "tweet_id": "1261421056574849026"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1256280966101942273"}, "tweet_id": "1261422414057148419"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "510816105"}, "tweet_id": "1261426438219194368"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1005722022830276608"}, "tweet_id": "1261429688569716737"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "2185707865"}, "tweet_id": "1261430171523002369"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1258427982869299203"}, "tweet_id": "1261450801144188928"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "401595141"}, "tweet_id": "1261453836503277568"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1236992477829181440"}, "tweet_id": "1261458787283554304"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1568190026"}, "tweet_id": "1261562917176119296"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1261626010149236737"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1261626047893852160"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "3063813839"}, "tweet_id": "1261638506880872448"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "155951455"}, "tweet_id": "1261752121013276672"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1109532876310302721"}, "tweet_id": "1262472759462047749"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "938729294578233344"}, "tweet_id": "1263774043943186433"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "3012355293"}, "tweet_id": "1263777864534700033"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "233345901"}, "tweet_id": "1263807838566187008"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "786118672343457793"}, "tweet_id": "1264443404685062145"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1018876515197517824"}, "tweet_id": "1264539357744160778"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "2610139748"}, "tweet_id": "1264659983540662273"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "718066634334846976"}, "tweet_id": "1265505112715399173"}, {"license": "gnip", "citation_ids": [82124185], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1270054329060167681"}], "patent": [{"title": "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10787501-B1", "license": "public", "citation_ids": [81686823, 79886706, 83946256, 81839528, 81950522, 78627096, 82099898, 84234572, 82123095, 81432678, 81687333, 84590251, 82776439, 82125287, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 82372636, 83326754, 83146578, 82236864, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 83816209, 76759624, 82241906, 82006689, 82127390, 83471779, 81898802, 82752495, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 79411573, 82846613, 84064050, 82136174, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 89309738, 92789824, 93046290, 42295981, 2000877, 4443560, 1927968, 4498119, 80912392], "posted_on": "2020-09-29T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10787501-B1", "jurisdiction": "US", "filing_status": "Grant"}, {"title": "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10954289-B1", "license": "public", "citation_ids": [81687333, 84590251, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 81686823, 79886706, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 82372636, 83326754, 83146578, 82236864, 83946256, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 82776439, 82125287, 83816209, 76759624, 4225088, 82241906, 82006689, 82127390, 84234572, 82123095, 81839528, 83471779, 81898802, 82752495, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 79411573, 81331345, 82846613, 84064050, 82136174, 81432678, 81950522, 78627096, 82099898, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 76348331, 78651983, 89309738, 86397980, 92789824, 83360939, 93046290, 42295981, 83349805, 84959013, 2000877, 79801422, 76810504, 4443560, 82104617, 1927968, 4498119, 80912392], "posted_on": "2021-03-23T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10954289-B1", "jurisdiction": "US", "filing_status": "Grant"}, {"title": "Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10975139-B1", "license": "public", "citation_ids": [81687333, 84590251, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 81686823, 79886706, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 83326754, 83146578, 82236864, 83946256, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 82776439, 82125287, 83816209, 76759624, 82241906, 82006689, 82127390, 84234572, 82123095, 81839528, 83471779, 81898802, 82752495, 4225088, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 81331345, 82846613, 84064050, 82136174, 81432678, 81950522, 78627096, 82099898, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 76348331, 78651983, 89309738, 86397980, 92789824, 83360939, 93046290, 42295981, 83349805, 84959013, 2000877, 79801422, 76810504, 4443560, 82104617, 1927968, 4498119, 80912392], "posted_on": "2021-04-13T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10975139-B1", "jurisdiction": "US", "filing_status": "Grant"}]}, "score": 15.35, "images": {"small": "https://badges.altmetric.com/?size=64&score=16&types=attttttt", "medium": "https://badges.altmetric.com/?size=100&score=16&types=attttttt", "large": "https://badges.altmetric.com/?size=180&score=16&types=attttttt"}}